ANDA 77643, held by Watson Labs. Topiramate.
As of Nov 15, 2026, ANDA 77643 (Topiramate), held by Watson Labs, was first approved by FDA on Mar 27, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2009 | Original application | Approved | None posted |
| Topiramate25MG · tablet;oral | Topiramate | Discontinued |
| Topiramate50MG · tablet;oral | Topiramate | Discontinued |
| Topiramate100MG · tablet;oral | Topiramate | Discontinued |
| Topiramate200MG · tablet;oral | Topiramate | Discontinued |
| Jan 21, 2010 | Supplement 1Labeling | Approved | None posted |
| Mar 27, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters